Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | PRKCA | P17252 | 1/20 | 0.39 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.39 |
| ▸ | P4HB | P07237 | 2/20 | 0.38 |
| ▸ | PDIA4 | P13667 | 2/20 | 0.38 |
| ▸ | PDIA3 | P30101 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13866334 | 1.00 | TSHR (0.47) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL14176116 | 1.00 | TSHR (0.47) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL18512780 | 0.91 | LMNA (0.43) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL18503487 | 0.90 | LMNA (0.40) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL13866335 | 0.89 | TSHR (0.46) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL14176117 | 0.89 | TSHR (0.46) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL14176115 | 0.89 | TSHR (0.46) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL13866336 | 0.89 | TSHR (0.46) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL17198439 | 0.89 | LMNA (0.39) | TSHRLMNAKMT2ACYP2D6ALDH1A1 | |
| SCHEMBL17198604 | 0.89 | TSHR (0.46) | TSHRLMNAKMT2ACYP2D6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112724180-B | Preparation method of beta-nicotinamide mononucleotide | 黄冈鲁班药业股份有限公司 | 2023-01-10 | — | — | CN | disclosed |
| CN-112724180-A | Preparation method of beta-nicotinamide mononucleotide | 黄冈鲁班药业股份有限公司 | 2021-04-30 | — | — | CN | disclosed |
| US-20150376219-A1 | Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods | ZHONG MINGHONG (US) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150376219-A1 | Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and Methods | PNP, ATIC, NT5C3B | TSHR 3393/4885LMNA 1004/4885KMT2A 3662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.